pgp9.5
PGP9.5 |
|||
RA12103 | Neuromics | 50 ul | 260.4 EUR |
PGP9.5/UCHL1 |
|||
MO22109 | Neuromics | 100 ul | 522 EUR |
PGP9.5/UCHL1 |
|||
MO25040 | Neuromics | 500 ul | 506.4 EUR |
PGP9.5/UCHL1 |
|||
RA22118 | Neuromics | 100 ul | 522 EUR |
PGP9.5 protein |
|||
30R-1093 | Fitzgerald | 100 ug | 366 EUR |
Description: Purified recombinant Human PGP9.5 protein |
|||
PGP9.5 Antibody |
|||
20-abx137400 | Abbexa |
|
|
PGP9.5 Antibody |
|||
abx219233-100ug | Abbexa | 100 ug | 526.8 EUR |
PGP9.5 antibody |
|||
10R-1055 | Fitzgerald | 100 ul | 379.2 EUR |
Description: Mouse monoclonal PGP9.5 antibody |
|||
PGP9.5 antibody |
|||
70R-30722 | Fitzgerald | 100 ug | 392.4 EUR |
Description: Rabbit polyclonal PGP9.5 antibody |
|||
PGP9.5 Antibody |
|||
AF0243 | Affbiotech | 200ul | 420 EUR |
PGP9.5 Antibody |
|||
AF5490 | Affbiotech | 200ul | 420 EUR |
PGP9.5 Antibody |
|||
49397-100ul | SAB | 100ul | 399.6 EUR |
PGP9.5 Antibody |
|||
49397-50ul | SAB | 50ul | 286.8 EUR |
PGP9.5 Antibody |
|||
49435-100ul | SAB | 100ul | 399.6 EUR |
PGP9.5 Antibody |
|||
49435-50ul | SAB | 50ul | 286.8 EUR |
PGP9.5 antibody |
|||
70R-50526 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal PGP9.5 antibody |
|||
PGP9.5 antibody |
|||
70R-50527 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal PGP9.5 antibody |
|||
PGP9.5 Antibody |
|||
33472-100ul | SAB | 100ul | 302.4 EUR |
PGP9.5 Antibody |
|||
33472-50ul | SAB | 50ul | 224.4 EUR |
PGP9.5 Antibody |
|||
ABF0243 | Lifescience Market | 100 ug | 525.6 EUR |
PGP9.5 Antibody |
|||
ABF5490 | Lifescience Market | 100 ug | 525.6 EUR |
PGP9.5 Antibody |
|||
20-abx008593 | Abbexa |
|
|
PGP9.5 Antibody |
|||
20-abx013178 | Abbexa |
|
|
PGP9.5 Antibody |
|||
abx012330-100ug | Abbexa | 100 ug | 526.8 EUR |
PGP9.5 Antibody |
|||
DF6854 | Affbiotech | 200ul | 420 EUR |
PGP9.5 Antibody |
|||
F47951-0.4ML | NSJ Bioreagents | 0.4 ml | 322.15 EUR |
Description: PGP9.5 is a Ubiquitin-protein hydrolase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. Also binds to free monoubiquitin and may prevent its degradation in lysosomes. The homodimer may have ATP-independent ubiquitin ligase activity. [UniProt] |
|||
PGP9.5 Antibody |
|||
F47952-0.4ML | NSJ Bioreagents | 0.4 ml | 330.65 EUR |
Description: UCHL1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Expression of UCHL1 is highly specific to neurons and to cells of the diffuse neuroendocrine system and their tumors. It is present in all neurons. |
|||
PGP9.5 Antibody |
|||
R35289-100UG | NSJ Bioreagents | 100 ug | 339.15 EUR |
Description: Additional name(s) for this target protein: PARK5, Ubiquitin carboxyl-terminal esterase L1 , UCHL1 |
|||
PGP9.5 175-191 |
|||
P10135 | Neuromics | 20 ug Blocking Peptide | 175.2 EUR |
PGP9.5 175-191 |
|||
GP14104 | Neuromics | 50 ul | 278.4 EUR |
PGP9.5 Rabbit mAb |
|||
A19101-100ul | Abclonal | 100 ul | 492 EUR |
PGP9.5 Rabbit mAb |
|||
A19101-200ul | Abclonal | 200 ul | 685.2 EUR |
PGP9.5 Rabbit mAb |
|||
A19101-20ul | Abclonal | 20 ul | 265.2 EUR |
PGP9.5 Rabbit mAb |
|||
A19101-50ul | Abclonal | 50 ul | 344.4 EUR |
PGP9.5 (Clone: 31A3) |
|||
MO25010 | Neuromics | 100 ul | 804 EUR |
UCHL1 / PGP9.5 Antibody |
|||
abx239218-100ug | Abbexa | 100 ug | 610.8 EUR |
PGP9.5 Antibody (UCHL1) |
|||
F52332-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: Ubiquitin-protein hydrolase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. Also binds to free monoubiquitin and may prevent its degradation in lysosomes. The homodimer may have ATP-independent ubiquitin ligase activity. |
|||
PGP9.5 Antibody (UCHL1) |
|||
F47951-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: PGP9.5 is a Ubiquitin-protein hydrolase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. Also binds to free monoubiquitin and may prevent its degradation in lysosomes. The homodimer may have ATP-independent ubiquitin ligase activity. [UniProt] |
|||
PGP9.5 Antibody (UCHL1) |
|||
F47952-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: UCHL1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Expression of UCHL1 is highly specific to neurons and to cells of the diffuse neuroendocrine system and their tumors. It is present in all neurons. |
|||
PGP9.5 Antibody (UCHL1) |
|||
F47953-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: UCHL1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Expression of UCHL1 is highly specific to neurons and to cells of the diffuse neuroendocrine system and their tumors. It is present in all neurons. |
|||
PGP9.5 / UchL1 Antibody |
|||
R31930 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: UchL1, also known as PGP9.5, is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Expression of UchL1/PGP9.5 is highly specific to neurons and to cells of the diffuse neuroendocrine system and their tumors. It is abundantly present in all neurons (accounts for 1-2% of total brain protein), expressed specifically in neurons and testis/ovary. The catalytic triad of UchL1/PGP9.5 contains a cysteine at position 90, an aspartate at position 176, and a histidine at position 161 that are responsible for its hydrolase activity. |
|||
PGP9.5 / UchL1 Antibody |
|||
RQ5295 | NSJ Bioreagents | 100ul | 356.15 EUR |
Description: The protein encoded by the UCHL1 gene belongs to the peptidase C12 family. This enzyme is a thiol protease that hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. This gene is specifically expressed in the neurons and in cells of the diffuse neuroendocrine system. Mutations in this gene may be associated with Parkinson disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
RQ5296 | NSJ Bioreagents | 100ul | 356.15 EUR |
Description: The protein encoded by the UCHL1 gene belongs to the peptidase C12 family. This enzyme is a thiol protease that hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. This gene is specifically expressed in the neurons and in cells of the diffuse neuroendocrine system. Mutations in this gene may be associated with Parkinson disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
RQ6534 | NSJ Bioreagents | 100ug | 356.15 EUR |
Description: UCH-L1, also known as PGP9.5, is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Expression of UCH-L1 is highly specific to neurons and to cells of the diffuse neuroendocrine system and their tumors. It is abundantly present in all neurons (accounts for 1-2% of total brain protein), expressed specifically in neurons and testis/ovary. The catalytic triad of UCH-L1 contains a cysteine at position 90, an aspartate at position 176, and a histidine at position 161 that are responsible for its hydrolase activity. |
|||
PGP9.5 / UchL1 Antibody |
|||
V3662-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V3662-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V3662IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V3662SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V9096-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V9096-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V9096IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V9096SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V9097-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, UchL1 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for UchL1 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in the gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V9097-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, UchL1 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for UchL1 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in the gene is believed to cause a form of Parkinson's disease. |
|||
PGP9.5 / UchL1 Antibody |
|||
V9097SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb reacts with a protein of 20-30kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, UchL1 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for UchL1 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in the gene is believed to cause a form of Parkinson's disease. |